Weave Communications Inc
NYSE:WEAV
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
8.32
16.12
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Earnings Call Analysis
Q3-2024 Analysis
Weave Communications Inc
In the third quarter of 2024, Weave reported impressive financial results with revenues reaching $52.4 million, reflecting over 20% year-over-year growth. This performance exceeded the midpoint of the guidance provided in July by $1.2 million. Notably, this quarter marked the company's first instance of achieving positive non-GAAP operating income, coming in at $1.4 million, an improvement of $3.2 million compared to last year. The overall operating income margin achieved was 2.7%, a significant improvement from a loss margin of 4.2% a year prior.
Weave's gross margin also improved to 72.5%, which includes an increase of over 300 basis points from the previous year. The cost of revenue only rose by 8%, while revenue surged, showcasing management's efficiency in scaling operations. Furthermore, the total operating expenses as a percentage of revenue decreased to 70%, down from 74% in Q3 of 2023, indicating a focus on cost optimization.
Customer retention metrics remained strong, with net revenue retention improving to 98%, up from 97% in the previous quarter. This increase highlights effective customer engagement strategies, particularly in the Specialty Medical vertical, which has been a significant driver of growth. The gross revenue retention rate was a remarkable 92%, consistently hovering between 91% to 94% over the past four years, positioning Weave as a top performer for small to medium-sized business retention.
A key highlight was the launch of the New Weave platform, deemed the most significant product launch in the company's history. This revamped platform enhances user interfaces and integrates advanced functionality such as AI-driven features to improve customer engagement. These improvements aim to substantially enhance operational efficiency for practices and improve patient communication workflows, thereby supporting revenue capture strategies.
Weave's strategy to integrate fintech solutions such as payment processing and flexible invoicing options resonates well with healthcare providers. The ability to offer payment plans and digital payment options has empowered practices to increase procedure acceptance rates and optimize billing operations. As a testament to this approach, we saw a year-over-year free cash flow increase of 70%, reaching $3.5 million in Q3 2024.
Looking ahead, Weave raised its revenue guidance for the full year 2024, now expecting total revenues between $202.7 million to $203.7 million. Furthermore, the guidance for the upcoming fourth quarter estimates revenue between $52.6 million and $53.6 million and operating income between $0.9 million and $1.9 million. This outlook demonstrates a confident trajectory based on ongoing customer acquisition and retention efforts.
Weave's recent partnership with Patterson Dental has led to higher conversion rates and improved sales, signifying the effectiveness of collaborative marketing efforts and training initiatives. This move is indicative of Weave's strategic focus on integrating with practice management systems, which broadens their addressable market, highlighted by recent integrations with recognized platforms like eClinicalWorks and others.
Good day, ladies and gentlemen, and welcome to Weave Third Quarter 2024 Financial Results Conference Call. [Operator Instructions]
At this time, it is my pleasure to turn the floor over to your host, Mark McReynolds, Head of Investor Relations. Sir, the floor is yours.
Thank you, Kat. Good afternoon, and welcome to Weave's Third Quarter 2024 Earnings Call. With me on today's call are: Brett White, CEO; and Alan Taylor, CFO.
During the course of this conference call, we will make forward-looking statements regarding the anticipated performance of our business. These forward-looking statements are based on management's current views and expectations, entail certain assumptions made as of today's date, and are subject to various risks and uncertainties described in our SEC filings. We've disclaimed any obligation to update or revise any forward-looking statements.
Further, on today's call, we will discuss certain non-GAAP metrics that we believe aid in the understanding of our financial results. Unless otherwise noted, all numbers we talk about today will be on a non-GAAP basis. A reconciliation to comparable GAAP metrics can be found in today's earnings release, which is available on our website and as an exhibit to the Form 8-K furnished with the SEC before this call, as well as the Earnings Presentation on our Investor Relations website at investors.getweave.com.
And with that, I will now turn the call over to Brett.
Thank you, Mark, and thanks to everyone for joining the call today. I'd like to start with a few financial highlights from Q3. We delivered another quarter of solid top line performance and significant improvements in gross and operating margins and free cash flow. We also achieved another major performance milestone, reporting positive non-GAAP operating income for the first time in the company's history.
Revenue for Q3 was $52.4 million, representing over 20% year-over-year growth and $1.2 million above the midpoint of the guidance range we provided in July. Gross margin reached 72.5%, an improvement from last quarter and over 300 basis points greater than Q3 of last year, marking our 11th consecutive quarter of gross margin improvement.
Weave's mission is to enhance health care experiences for both patients and the practices that serve them. We deliver an all-in-one customer experience and payment software platform specifically designed for small- and medium-sized health care practices. Our solution enables health care providers to focus on patient care while we help optimize office operations, streamline billing and payment processing and drive practice growth through improved patient communication and engagement.
Our current focus is on dental, optometry, veterinary and specialty medical verticals, which we estimate is an addressable market exceeding $7 billion in the U.S. alone. Specialty medical, which includes family practice, MedSpa, Plastic Surgery and Physical Therapy was our fastest-growing category again in Q3.
Our origins are in helping practitioners grow their businesses by effectively attracting, engaging and retaining patients. The integration of fintech solutions like payment processing; Buy Now, Pay-over-time; and payment plans is a natural progression to help practitioners accelerate collections and increase acceptance rates of additional services. With Weave, billing and payment requests are seamlessly integrated into communication workflows using the practice's trusted phone number and domain. This approach streamlines payment time lines, reduces accounts receivable and write-offs and further supports practice growth and profitability.
Health care providers, often without dedicated IT, business intelligence, finance or marketing teams rely on intuitive software like Weave to succeed. Our platform integrates seamlessly with practice management systems, enabling greater personalization, more automation and improved data accuracy. Last week, we announced the availability of the New Weave platform, which is the most significant product launch in our company's history. This is a culmination of a multiyear effort that holds great strategic importance for Weave and our customers.
Now available across all customer locations, the New Weave platform strengthens our market position with a robust, scalable and cutting-edge technology infrastructure that enables us to accelerate innovation. Weave has been at the forefront of administrative AI solutions for health care practices and an AI-powered Weave Assistant is integrated throughout the new platform. Our unique advantage is that we have more than a decade of patient interactions available to train large language models. This unique training data set includes billions of records like phone calls, voice mails and SMS messages.
Our AI-powered features provide immediate customer value. [ McKinsey ] reports that AI tools could automate nearly 45% of administrative tasks in the health care sector, potentially saving $150 billion annually. Weave Assistant helps craft personalized responses to reviews, write professional branded e-mails and automate tasks like message tagging and voice mail transcriptions. Our new call intelligence product leverages a custom AI model to extract actionable insights from call data.
To keep their businesses running smoothly, our customers must manage communications and payments workflows simultaneously. The New Weave platform improves practice operations by consolidating tasks into a more unified system. It features a modern user interface that prioritizes versatility and ease of use, streamlining daily tasks with fewer steps and clicks. Pop-out texting and Team chat allows users to text patients, chat with staff, accept a phone call and view the calendar all at the same time. Users can toggle between locations to access one or all locations and configure forms, messages and other settings once for a single location or multiple locations with ease.
The New Weave platform features an enhanced user interface, which can now expand to full screen for a comprehensive view or shrink to fit seamlessly alongside the practice's system of record. A fully customizable dashboard places the most essential elements front and center, providing a helpful overview of the day. The New Weave platform is available via mobile app, desktop app or any browser. Security and software updates are installed automatically, ensuring the platform stays up to date without any extra effort on the part of our customers.
I invite you to watch a 2-minute video on our website to see firsthand the exciting leap forward our new platform represents for our customers. Take a look at getweave.com/new. Last week, we also launched an enhanced e-mail marketing tool on the New Weave platform, enabling the easy creation of professional on-brand e-mails with a drag-and-drop composer, prebuilt templates and free stock images. E-mails can be sent from the trusted business domain to ensure professionalism and help avoid spam filters. Our IR -- AI-powered Weave Assistant helps craft content while advanced filters target the right audience.
The New Weave platform also introduces a new specialized user interface for veterinary practices. These UI enhancements built in collaboration with veterinary professionals streamline daily operations and improve the experience for clinic staff and clients. By making pets the primary profile across the Weave platform, the update enables more personalized service and allow front desk staff to quickly access essential pet details.
In addition to enhancements to our user experience and AI-powered features, the New Weave platform opens up valuable opportunities for seamless integration of payments functionality into communication workflows via the trusted practice phone number. By embedding billing and payment features throughout the entire patient journey from appointment scheduling to post-visit text-to-pay notifications, we simplify and enable customers to accelerate the billing and collection process.
With Weave Payments, our customers can easily allow their patients to pay using their preferred methods. Practices can send payment requests via text-to-pay, accept payments through credit cards or ACH direct debit and offer online and in-person payment options like online bill pay, scan to pay and mobile tap to pay. Practices can also keep payment methods on file and provide flexible options such as Buy Now, Pay-over-time and payment plans. This empowers practices to increase procedure acceptance rates, optimize billing operations, improve collections on past due accounts and reduce write-offs.
In Q3, we've also announced payment reminders. This new feature allows our customers to collect more outstanding balances with less effort by turning each Weave payment invoice or text-to-pay request into an automated collection campaign. As we announced last quarter, the New Weave platform powers Weave Enterprise, our solution designed specifically for multi-location practices. Approximately 1/3 of our active locations are part of multi-location group, and Weave Enterprise offers advanced capabilities like a unified inbox for appointments and forms, centralized management tools, region-specific reporting and robust payment and collection features.
We're very excited to share an early success story for the New Weave platform and our Enterprise product. Earlier today, we announced that Affordable Care, America's largest dental support organization for tooth replacement services has selected Weave as the platform of record for patient engagement and payments across its supported dental practices. Affordable Care chose Weave for our ability to integrate seamlessly with their databases, streamline and automate patient engagements and provide new digital payment options that fit naturally into patient communication workflows.
Since implementing Weave, Affordable Care pilot locations have achieved measurable improvements in operational efficiency through online scheduling and digital forms by also seeing boost in patient acquisition and treatment acceptance rates. These practices report increased cash flow and revenue capture per location, driven by flexible payment options that optimize revenue cycle management and enhance overall patient experience.
To further drive growth in the multi-location space, we have recently added a seasoned leader with 20 years of industry experience to head our multi-location sales team. His experience, strategic vision and strong market relationships will play a crucial role in Weave's presence, particularly among Dental Service Organizations, or DSOs.
On the partnership front, we continue to make progress. Our authorized and supported integrations with leading practice management systems empowers practices to automate and personalize their communications and play a critical role in driving growth across our target markets. This year, we have expanded our addressable market through new integrations with eClinicalWorks, athenahealth, NextGen, EzyVet and other practice management systems. We've also deepened existing integrations with Dentrix Ascend, Eaglesoft and Fuse to include reading and writing patient information, appointment details, confirmations and ledger entries to streamline payments collections, helping practices further enhance efficiency and accelerate growth.
Even more compelling, we have advanced our strategic approach by forming deeper commercial partnerships. In June, we announced a strategic agreement with Patterson Dental, offering one of the most comprehensive integrations in the market and enabling co-marketing and co-selling initiatives. Since then, close collaboration between Weave and Patterson leadership has enhanced value for our shared customers, resulting in improved conversion rates at every stage of the sales cycle and bookings growth.
Finally, Weave continues to earn recognition for our dedication to delivering exceptional customer experiences and the outstanding performance of our platform and team. In G2's Fall 2024 Report, we've ranked first in 21 categories and was once again named the leader in the grid for patient relationship management and was listed among the top 50 software products for small businesses. Additionally, Weave was named an Inc. Power Partner, recognizing our impact in helping businesses start, run and grow. We are committed to fostering an exceptional workplace, and Weave is now Great Place to Work certified in the U.S. for sixth consecutive year and for the first time in India.
In closing, I'm incredibly proud of the Weave team's achievement in Q3 as we continue our momentum from the first half of the year. We drove strong top line growth, made solid progress in profitability and brought to market some truly innovative new products. This success reflects our commitment to putting our customers first and constantly delivering solutions that meet their needs. I want to sincerely thank our customers, partners, team members and shareholders for their ongoing support of Weave.
With that, I'll hand the call over to Alan to dive deeper into the financial results and share our outlook. Alan?
Thanks, Brett, and good afternoon, everyone. I'm excited to share some additional insights on our financial performance this quarter. In Q3, we continued to execute well, and we're pleased with our results.
As Brett mentioned, we are excited about hitting $1.4 million in positive non-GAAP operating income. This operating income result represents a $2.1 million beat over the midpoint of the guidance range we provided last quarter. We delivered this significant milestone of non-GAAP operating income for the first time in the company's history while achieving third quarter revenue of $52.4 million and maintaining a revenue growth rate of over 20%. Revenue growth this quarter was largely fueled by new customer acquisitions with continued momentum from our Specialty Medical vertical, which is growing at more than twice the rate of our overall revenue growth with notable success among MedSpas and general practitioners. Our net revenue retention rate improved to 98% in Q3, up from 97% last quarter.
Our upsell products have continued to perform well. We've continued to increase the number of payments customers, and we've also benefited from price adjustments, which are periodically made across customer cohorts and products as we continuously deliver additional value and functionality like the New Weave platform.
Our gross revenue retention rate remained strong at 92%, placing us among the top performers for SMB retention. Weave's gross revenue retention rate has consistently ranged between 91% and 94% each quarter over the past 4 years. Transitioning to a deeper look at our operating results, as a reminder, I'll be referring to non-GAAP results unless stated otherwise.
In Q3, -- we achieved solid improvements across the board. Our gross margin reached 72.5%, greater than a 300 basis point increase year-over-year. Cost of revenue rose by only 8% year-over-year, while revenue grew by over 20%. Our total operating expenses as a percent of revenue improved to 70% this quarter, down from 74% in Q3 of 2023, reflecting our continued focus on optimization. Sales and marketing expenses came in at $19.4 million or 37% of revenue, a slight decrease from 38% in the same period last year. Research and development expenses for the quarter totaled $8 million, representing 15% of revenue, down from 16% of revenue a year ago. Additionally, general and administrative expenses were $9.2 million or 17% of revenue compared to $8.3 million or 19% of revenue in the prior year period. These improvements highlight our focus on efficiency and productivity as we scale our operations.
As previously mentioned, operating income for Q3 was $1.4 million, an improvement of $3.2 million compared to last year and $1.6 million higher than the top end of the guidance that we gave in July. The corresponding operating income margin of 2.7% is a significant improvement from the operating loss margin of 4.2% last year. Our net income was $2.1 million or $0.03 per share in the third quarter based on 72 million weighted average shares outstanding. This is compared to a net loss of $1 million or $0.01 per share last year. This represents a $3.1 million improvement due to revenue growth and operating efficiencies.
Adjusted EBITDA was positive $2.2 million, a $3.2 million improvement year-over-year. Adjusted EBITDA margin of positive 4% was a significant improvement compared to the negative 2% margin reported a year ago.
Shifting the focus to the balance sheet and cash flow. We ended the third quarter with $98.2 million in cash and short-term investments. Cash flow generated from operations was $4.5 million in the third quarter and $7.5 million year-to-date. Free cash flow was $3.5 million in the third quarter, representing year-over-year growth of 70% and $4.2 million year-to-date.
Turning to our outlook. We are raising our guidance for the full year 2024, and we expect total revenue to be in the range of $202.7 million to $203.7 million. We also expect to produce positive non-GAAP operating income for the full year 2024. For the fourth quarter of 2024, we expect total revenue in the range of $52.6 million to $53.6 million and non-GAAP operating income in the range of $0.9 million to $1.9 million. We expect to have a weighted average share count of approximately 71.6 million shares for the full year.
In summary, we've continued to execute well in Q3, and we're excited about the success we're having across all the verticals that we serve. We're optimistic about our future opportunities and are committed to strengthening our long-term value through sustained business growth.
And with that, I'll turn the call back over to the operator for Q&A.
And our first question comes from Brett -- Brent Bracelin from Piper Sandler.
Great to see the profitability crossover this quarter. I had 2 questions, if I could here. One, when could the new Patterson relationship here start to have a bigger impact on the pipeline, top of funnel?
And then two, I was hoping you could talk a little bit about Specialty Medical, what's driving the momentum there? And maybe more specifically, could you frame how the New Weave enterprise platform could expand your reach into hospitals? It looks like hospitals are now one of the areas you could go after with that new platform.
All right. Thanks, Brent. Let me break this down. Okay. Let's start with Patterson. When do we expect that to start affecting kind of funnel? It's happening now. So we saw -- we originally announced -- we built the integration. We announced the partnership. We went to their sales conference, trained about 700 of their reps, and then we've gone to visit them and train their sales teams. I think we've done 3 or 4 of those, and we're actually seeing it show up in the results now. We're getting higher conversion rates all through the funnel. We're getting growing bookings. So the Weave sales on the Patterson platform have definitely increased, and we expect that momentum to continue.
Perfect. And then could you talk a little bit about the Specialty Medical and maybe a little bit more about Weave Enterprise. I do see you're targeting hospitals now on the website. I'd love to understand that opportunity. I know historically, you haven't addressed larger hospitals. I'd love to know what Enterprise opens up for you, particularly given that Proofpoint with Affordable Care in their 450 locations?
Sure. So Specialty Medical is really quite fragmented. So the success we're seeing there is really around building the integrations. As we build the integrations, there's really a pent-up demand, I think, to move off of a lot of their point solutions onto an integrated platform. So that's really why we're seeing a lot of success there. As we roll out the integrations, as we get the payments integrations written and the sales teams trained, we're seeing a lot of success there. So I expect that to continue to grow. Actually, Specialty Medical in aggregate is a larger market than Dental, Opto and Vet. So we're very excited about what we're seeing there.
And as far as hospitals, we're really focused on small- and medium-sized practices. So the multi-location -- we view the multi-location opportunity as just an aggregation of small- and medium-sized locations. So as you mentioned, Affordable Care is 450 locations. They're -- it's a very large enterprise, and we're seeing great opportunity with those. The New Weave enterprise platform really fits well for their needs and their use case and the Affordable Care win really proves that out. Once you bring a multi-location, a modern multi-location product together with really deep integrations as we have in this case with the Affordable Care solution and payments, it's just a winning combination.
And in fact, you probably noticed in my comments or in the press release, Affordable Care selected us not only for the Engagement solution, the Communication Engagement solution, but also all of their payments, which is a terrific win. So we're not really, at this point, targeting large hospitals. We've got more than enough opportunity just in the single location and the multi-location businesses.
And our next question comes from Alex Sklar from Raymond James.
Alan or Brett, just starting off with the first question on the outlook for NRR. It's picked up nicely in the last couple of quarters. Can you just help frame where you see some of the biggest opportunities to get that figure even higher?
I know you talked about payments being a big bucket. What is maybe some of the other lowest hanging fruit if you look at that metric in particular?
Yes. Thanks, Alex. So NRR payments clearly is one of the big ones with the increased take rate that we're seeing through partnerships like Patterson as well as just across our sales team. We continue to expand payments. It's growing faster than our business as a whole, the revenue growth as a whole. And so that will be a key component. We are also introducing some very great upsell products that we've talked about with call intelligence and bulk messaging and insurance verification and forms. These are kind of coming into their own to be a substantial part of the quarterly revenue that's helping us to grow our NRR. And so those are the things that we are going to continue to emphasize. We're going to continue to improve those so that we -- the downgrade rates improve as well. And those are really the focus areas for increasing the NRR.
Alex, I would add that as we build out more of these integrations, we have greater opportunity within our installed base to move from customers who are maybe running Weave stand-alone in a nonintegrated way on to an integrated platform. And then -- and when that happens, they just have access to more functionality and it's just a lot stickier; and obviously, it's an upsell.
Great. That's great color. Maybe a follow-up for you, Brett, just on Specialty Medical broadly. So 4 core subverticals today. I think you talked about it going to 8. How is your sales coverage broadly for that opportunity? And then, what do you need to see? It's already growing twice as fast as kind of the overall organization you said. What do you need to see to kind of take that formal go-to-market hiring from 4 to 8 of the subverticals to something north of 10 or 20 over the next couple of years?
Yes. So again, we keep coming back to this. Integrations are really, really important. And so when -- in order for us to enter into a new vertical, we want to be able to integrate with the Practice Management Software that is predominant in that subvertical. We want to make sure that we have really good product market fit. And as you can kind of tell, the way we've been rolling out verticals over the last couple of years, we're quite thoughtful about it. So we're going to be adding new verticals, but not just adding them for adding sake, but we're going to make sure we got good product market fit, adding integrations and then delivering more and more value.
Outside of the verticals where we currently are, it is actually very, very fragmented. So the market is there. It's ripe for us to bring our solution into those verticals. And we just want to do it in a very thoughtful and successful way. So we have kind of a win-win relationship with our customers on Day 1.
I would just add, Alex, we are seeing inbound interest from customers for whom we do not have an integration. These folks are pretty starved for a solution like Weave to communicate with their patients. And so it represents a great opportunity for us to know where the biggest interest is and make sure that we got on our road map, the integrations that will even better serve them in the future.
Great. And maybe just a quick follow-up on both of those about the inbound, are you seeing any increase in inbound interest from those fragmented practice management systems that they're looking to build the integrate -- they're being more proactive saying, "Hey, can we build the integration to you all and speed up the process?" Is that at all inflected from your seat?
Yes, very much so.
And yes, and I'll add another little anecdote there. When we go into an event, an on-site event, trade show, whatever it may be, and we put up a banner in our booth that says "We now integrate with XYZ", we get a lot of attention. So there's definitely demand.
And the other great thing is 1.5 years ago, a lot of Practice Management Software kind of viewed us as a competitor, and they were not super interested in working with us. And really, it took a mindset shift on our side to show that we're interested in a win-win relationship with the PMS vendors -- and it's almost done a 180, where now we have Practice Management Software vendors coming to us and asking us to integrate, and it's really just building the queue to write the integrations and then develop the go-to-market plan. So we're quite optimistic on moving into new verticals and deepening the quantity and the depth of the integrations that we have.
And our next question comes from Parker Lane from Stifel.
Alan, you alluded to some price adjustments that you periodically do. I'd love to get some more color on where those took place. And longer term, you bring a lot of functionality to the table here. How should we think about your ability to, I guess, extract more price for some of these more premium-type features that you're bringing to the table?
Yes. Thanks, Parker. Price adjustments are something that we do every quarter. We manage those usually based on a cohort basis of when the customers renew, but they also are based on product changes. We're always experimenting with bundles. So we have found that so long as we are delivering value, just like the New Weave platform that our customers are tolerant of these price increases, particularly we're just kind of exiting a fairly high inflationary period. But -- so yes, we will continue to do that and manage those prices, making sure that we are delivering the value that warrants that.
And in terms of extracting, it's all about wallet share. Payments helps us with that. Getting into the workflows of these customers is key. That includes the integrations, the better that we're able to integrate with payments and to record those payments to eliminate reconciliation efforts at the office to just improve the lives of the office staff, that's where we win. And they know that we represent one of the best solutions out there. And so they're willing to pay for that so long as we continue to deliver, and that's what we intend to do.
Parker, one thing I would add is the New Weave platform is a vastly superior product to the legacy app in kind of every possible way. And right now, it's available to all of our customers, existing and all new customers at no additional charge, even though it's a significantly more valuable product. So I think we've got opportunity there in the future. But right now, it's just an upgrade at no additional charge.
Brett, just a follow-up on that. Is there any time line by which customers will sort of adopt that newer platform? Is there going to be a big changeover moment for everyone? Is it a case-by-case basis? Just coming from a change management standpoint, how you're handling that?
Yes. So it's our desire to move customers over sooner rather than later just so they can get a lot of the benefits. I mean, one of the great benefits is they get updates to the software as they're developed and pushed out as opposed to having to go in and update their app. So they kind of have to constantly have the best solution that's available to them. So it's to their benefit to move over quickly, but we understand that there will always be folks who are just comfortable with what they're using. And we don't have any plans at this time to kind of force people over. We just hope that they get the word through our marketing initiatives and our pop-ups that, "Hey, give us a try, and I think you'll like it." And sooner is better for everyone.
And our next question comes from Mike Funk from Bank of America.
This is Matt on for Mike. Great to see the profitability this quarter and continued gross margin expansion. Maybe if you could just help us frame some of the drivers for potential future margin improvement as a whole. And then maybe help us think about where terminal gross margins can end up in a couple of years out?
Thanks, Matt. Yes, the gross margin has been a great story. As we mentioned, it's 11 quarters of continued expansion. The drivers there continue to be around the payments product on the revenue side. As we continue to extend that payment product into our existing customer base as well as new customers, that's a positive factor for gross margin expansion. We also -- the phone component of our go-to-market comes off amortization after 3 years. And so it sets us up with just kind of a structural improvement as those phones come off amortization and customers stay with us as we go along. So that's an improvement.
And then just everything -- every other category. We've got a support organization that is focused on delivering world-class service while managing costs. They're putting into place new tools and processes, including some significant ones in the last quarter that are just allowing us to do a better job of servicing the customers without having to grow that staff. And when an Engineering organization that is focused on our delivery through all of our data centers, the bandwidth providers that provide to us, they're doing a great job of managing those costs and our scale helps us with some efficiencies there as well.
Long-term, with respect to the gross margin, we see ourselves in 75% to 80% gross margin company. And that's where we know we can get to as we continue to go on and just improve payment success and keep a vigilant eye on all [ other ] costs.
And at this time, there are no more questions. I would now like to turn it back to management for any closing remarks.
Yes. I'd like to just kind of circle back on a question we got at the beginning of the call, and it was a question around kind of how our relationship with Patterson was turning out. And one observation I'd like to share, which is very exciting for us is that the adoption of Weave payments at the time of sale of the Weave platform on Patterson is very, very high. It's higher than our core business. So that would be adoption of payments at sale of the software. And so that's a very encouraging sign as well.
So with that said, I'd like to thank the entire Weave team. I'd like to thank everyone, all of our shareholders for your support. Thank you for joining the call. We here are really excited to continue to build on the progress that we've made to deliver improved outcomes for both our customers and our shareholders over the coming quarters. So thank you.
Thank you. This does conclude today's conference. We thank you for your participation. You may disconnect your lines at this time, and have a wonderful day.